RT Journal Article
SR Electronic
T1 Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy
JF Journal of Neurology, Neurosurgery & Psychiatry
JO J Neurol Neurosurg Psychiatry
FD BMJ Publishing Group Ltd
SP 663
OP 666
DO 10.1136/jnnp.33.5.663
VO 33
IS 5
A1 Osuntokun, B. O.
A1 Langman, M. J. S.
A1 Wilson, J.
A1 Aladetoyinbo, A.
YR 1970
UL http://jnnp.bmj.com/content/33/5/663.abstract
AB The results are presented of a double-blind therapeutic trial of hydroxocobalamin and riboflavine in Nigerian patients suffering from a degenerative neuropathy. Although no benefit from either vitamin was demonstrated, this may reflect the inadequacy of the dosages used. The results are discussed in relation to the hypothesis that dietary cyanide and cyanogens are responsible, at least in part, for the occurrence of this disease in a malnourished population.